FFM
BCAX

Fairmount Funds Management’s Bicara Therapeutics Inc. Common Stock BCAX Stock Holding History

Fairmount Funds Management’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-784,170
Closed -$10.2M – 18
2025
Q1 		$10.2M Sell
784,170
-499,999
-39% -$6.51M 1.59% 15
2024
Q4 		$22.4M Hold
1,284,169
– – 2.22% 15
2024
Q3 		$32.7M Buy
+1,284,169
New +$32.7M 2.65% 13